Musad, Norkisa T.

HRN: 29-21-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2026
CEFUROXIME 750MG (VIAL)
06/29/2026
07/06/2026
IV
750mg
Q8H
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: